Biotechnology

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 results

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 resultsEarnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 results

Eli Lilly and Company (NYSE: LLY) on Tuesday reported double-digit growth in revenues and adjusted earnings for the fourth quarter…

ABBV Earnings: Everything you need to know about AbbVie’s Q4 report

ABBV Earnings: Everything you need to know about AbbVie’s Q4 reportABBV Earnings: Everything you need to know about AbbVie’s Q4 report

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The…

Eli Lilly and Company all set to report Q4 results. Here’s what to expect

Eli Lilly and Company all set to report Q4 results. Here’s what to expectEli Lilly and Company all set to report Q4 results. Here’s what to expect

Pharmaceutical company Eli Lilly and Company (NYSE: LLY) is preparing to report fourth-quarter earnings. In recent years, the drugmaker successfully…

MRK Earnings: Highlights of Merck’s Q4 2023 financial results

MRK Earnings: Highlights of Merck’s Q4 2023 financial resultsMRK Earnings: Highlights of Merck’s Q4 2023 financial results

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp fall in adjusted earnings for the fourth quarter of…

Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report

Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings reportInfographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report

Abbott Laboratories (NYSE: ABT), a diversified healthcare services company, Wednesday reported its fourth quarter 2023 financial results. Net income, excluding special…

Walgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimates

Walgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimatesWalgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimates

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the first quarter of 2024. Net…

Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody

Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibodyOcean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said that new findings, co-authored by the company’s scientific co-founder Jack…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research SummaryOcean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company focused on transforming biomedical inventions into cutting-edge therapies. The company develops…

Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023

Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research…

Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research SummaryTrxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As…

Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023.…

Gilead Sciences reports Q3 earnings. Here’s everything you need to know

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of…

Gilead Sciences Q3 2023 Earnings: Stay tuned for the live earnings call and real-time transcript

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, will be reporting third-quarter results today at 4:00 p.m. ET.…

VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results

Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The…

Vertex Pharma Q3 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is scheduled to publish earnings for the third quarter of 2023, today at…

REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase

Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third…

AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results

Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023.…

BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also…

Earnings Summary: Highlights of Centene Corp’s Q3 2023 earnings report

Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced third-quarter 2023 earnings results, reporting a sharp increase in revenues…

Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand…

Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in…